FDA Approves Opdivo (nivolumab) as Adjuvant Treatment of Completely Resected Esophageal or Gastroesophageal Junction Cancer in Patients who have Received Neoadjuvant Chemoradiotherapy
PRINCETON, N.J.--(BUSINESS WIRE) May 20, 2021 -- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved Opdivo® (nivolumab, injection for intravenous use) for the adjuvant treatment of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 20, 2021 Category: Drugs & Pharmacology Source Type: news
How Long Do You Live After Being Diagnosed With Esophageal Cancer?
Title: How Long Do You Live After Being Diagnosed With Esophageal Cancer?Category: Diseases and ConditionsCreated: 5/14/2021 12:00:00 AMLast Editorial Review: 5/14/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 14, 2021 Category: Cancer & Oncology Source Type: news
Esophageal Cancer: Preop Chemoradiotherapy Benefit for 10 Years Esophageal Cancer: Preop Chemoradiotherapy Benefit for 10 Years
Among patients with locally advanced resectable esophageal or junctional cancer, the overall survival benefit conferred by preoperative chemoradiotherapy persists for at least 10 years.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 13, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Michael Atkinson obituary
My mentor and friend Michael Atkinson, who has died aged 95, was for many years professor of gastroenterology at the University of Nottingham, where one of his most important contributions was the development of the Atkinson tube, which helps people with oesophageal cancer to swallow.Born in Rawdon, just outside Leeds, to Herbert, a plumbers ’ merchant, and his wife, Janet (nee Palliser), a postmistress, Michael went to Aireborough grammar school in West Yorkshire, then University College London for his medical education during the second world war.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - May 13, 2021 Category: Science Authors: John Bennett Tags: Medical research Medicine Cancer research Hospitals Health NHS Leeds University of Nottingham Source Type: news
Esophageal cancers resurrect ancient retroviruses hidden in our genome
(Columbia University Irving Medical Center) Scientists have found that many esophageal cancers turn on ancient viral DNA embedded in our genome, a finding that could lead to improvements in immunotherapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 10, 2021 Category: International Medicine & Public Health Source Type: news
Increased use of minimally invasive non-endoscopic tests for Barrett's esophagus screening
(American College of Physicians) The authors of a new commentary from Mayo Clinic suggest that more extensive use of minimally invasive non-endoscopic tests for Barrett's esophagus (BE) screening could impact early detection and prevention of esophageal adenocarcinoma (EAC), a particularly deadly form of cancer. This is important because BE, the only known precursor to esophageal cancer, is often asymptomatic. Their commentary is published in Annals of Internal Medicine. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 3, 2021 Category: Infectious Diseases Source Type: news
What Are the Stages of Esophageal Cancer?
Title: What Are the Stages of Esophageal Cancer?Category: Diseases and ConditionsCreated: 4/30/2021 12:00:00 AMLast Editorial Review: 4/30/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 30, 2021 Category: Cancer & Oncology Source Type: news
Humana partially reverses PET/CT policy
Humana will begin covering PET/CT imaging for gastric and esophageal oncologi...Read more on AuntMinnie.comRelated Reading:
FDG-PET/CT may increase survival in SCC patients
FDG-PET/CT effective for staging in new breast cancer
SNMMI provides update on COVID-19 vaccine and PET/CT
PET/CT shows link between stress and fatal heart condition
Nuclear medicine groups oppose Humana PET/CT policy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 27, 2021 Category: Radiology Source Type: news
Sculpting radiation beam spares lung cancer patients from severe, disabling complication
(Massachusetts General Hospital) The use of a novel esophagus-sparing technique reduces the rate of severe inflammation of the esophagus in patients with localized lung cancer receiving high-dose radiation and concurrent chemotherapy. Severe esophagitis was reduced despite tumors located within 1 centimeter of the esophagus, with no increased risk in local tumor recurrence. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 22, 2021 Category: Cancer & Oncology Source Type: news
Esophage cancer: Discovery of the mechanisms involved
(Universit é libre de Bruxelles) Publication in Cell Stem Cell: Researchers at the Universit é libre de Bruxelles, ULB uncover a new mechanism involved in the development of metaplasia in the oesophagus. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 21, 2021 Category: International Medicine & Public Health Source Type: news
Opdivo Plus Chemotherapy Approved for Treatment of Gastric Cancer
TUESDAY, April 20, 2021 -- Opdivo (nivolumab) is now approved for the treatment of advanced or metastatic gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma, the U.S. Food and Drug Administration announced Friday.
The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 20, 2021 Category: Pharmaceuticals Source Type: news
How Curable Is Cancer of the Esophagus?
Title: How Curable Is Cancer of the Esophagus?Category: Diseases and ConditionsCreated: 4/19/2021 12:00:00 AMLast Editorial Review: 4/19/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - April 19, 2021 Category: Cancer & Oncology Source Type: news
FDA Approves Opdivo (nivolumab) in Combination with Chemotherapy for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma Regardless of PD-L1 Expression Status
PRINCETON, N.J.--(BUSINESS WIRE)-- April 16, 2021
Opdivo is the first and only immunotherapy in combination with chemotherapy to deliver superior overall survival versus chemotherapy alone in a trial of this patient population1
U.S. Food and... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 16, 2021 Category: Drugs & Pharmacology Source Type: news
FDA approves nivolumab in combination with chemotherapy for metastatic gastric cancer and esophageal adenocarcinoma
Hematology / Oncology (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 16, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Consumer Health: Treating esophageal cancer
April is Esophageal Cancer Awareness Month, which makes this a good time to learn more about treating esophageal cancer, the sixth most common cause of cancer deaths worldwide. Esophageal cancer is more common among men than women, and it can occur anywhere along the esophagus. Signs and symptoms of esophageal cancer include difficulty swallowing, unexplained [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 12, 2021 Category: Databases & Libraries Source Type: news
